Quantcast
Last updated on April 16, 2014 at 4:43 EDT

Latest Illumina Stories

2014-01-27 12:29:12

DALLAS, January 27, 2014 /PRNewswire/ -- New analysis from MarketsandMarkets "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018", finds that the Global Genomics Market earned revenues of $11.11 billion in 2013 and estimates this market to reach over $19.0 billion by 2018....

2014-01-22 08:29:55

New Illumina system is designed to sequence whole genomes ten times as fast at one third of the cost NEW YORK, Jan. 22, 2014 /PRNewswire/ -- The New York Genome Center (NYGC) announced the acquisition from Illumina of a HiSeq X Ten system, which is expected to enable ultra-high throughput sequencing of whole human genomes. This advanced technology is designed to provide a prompt readout of the entire genome, dramatically enhancing the turnaround for valuable genomic information. With...

2014-01-17 12:25:14

DUBLIN, January 17, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/zqlcks/biochip_products) has announced the addition of the "2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/zqlcks/biochip_products ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The U.S. biochip product market held majority...

Thousand Dollar Genome
2014-01-15 12:43:36

Brett Smith for redOrbit.com - Your Universe Online A thousand bucks can get you that new MacBook Air or serve as a sizeable down payment on a new car. But a longer-term investment might be to sequence your entire personal genome. On Tuesday, Ilumina, the world’s leading seller of gene sequencing machines, unveiled HiSeq X Ten– the first supercomputer made to process 20,000 human genomes annually at a cost of $1,000 each. At a conference in San Francisco, Illumina’s CEO Jay...

2013-12-24 08:23:28

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, December 24, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Humana Inc. (NYSE: HUM), Illumina Inc. (NASDAQ: ILMN), Edwards Lifesciences Corp. (NYSE: EW), Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) and CytRx Corporation (NASDAQ: CYTR). Today's readers may access these reports free of charge - including full price targets, industry analysis and...

2013-12-23 08:26:20

--Revenues from Sales of ThruPLEX®-FD Prep Kits and PicoPLEX(TM) WGA Kits Increased 85%; Higher Volumes are Enabling 2014 Price Reductions-- ANN ARBOR, Mich., Dec. 23, 2013 /PRNewswire/ -- Rubicon Genomics, Inc.,(Rubicon) today reported major gains in 2013 sales of its nucleic acid library preparation products, ThruPLEX(®)-FD Prep Kits and PicoPLEX(TM) WGA Kits, resulting in an increase in company revenues of 85%. James Koziarz, PhD, CEO of Rubicon Genomics, commented, "This has...

2013-12-12 08:30:41

DUBLIN, Dec. 12, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/554xlp/next_generation) has announced the addition of the "Global Next Generation Sequencing (NGS) Market Report 2013-2017" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The NGS platforms market was dominated by Illumina in 2012, which accounted for the largest market share of 56%. Other companies with commercial platforms include Life Technologies (U.S.),...

2013-12-03 23:20:49

This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends. http://www.marketsandmarkets.com/Market-Reports/genechips-367.html (PRWEB) December 03, 2013 The “Global DNA and Gene Chip (Microarrays) Market (2010 - 2015)”, analyzes the DNA microarray market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for...

2013-12-02 23:02:04

MPLN acquires the Illumina MiSeqDx™ next generation sequencing system to expand its portfolio of molecular testing and clinical research services to support growing demand in personalized medicine Maryville, TN (PRWEB) December 02, 2013 Molecular Pathology Laboratory Network, Inc. (MPLN) announced today that it has acquired the Illumina MiSeqDx™, currently the only next generation sequencing system approved by the US Food and Drug Administration (FDA). MPLN will be the first...

2013-12-02 04:20:56

NIEL, Belgium, December 2, 2013 /PRNewswire/ -- Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching a CE/IVD labeled MID kit for Illumina(R) MiSeq(R) together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young (MODY), autosomal...